Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Charles Drew University of Medicine and Science
Health Clinics Limited
Assistance Publique - Hôpitaux de Paris
NKGen Biotech, Inc.
St. Joseph Hospital of Orange
National Cancer Institute, Egypt
McMaster University
Western Regional Medical Center
M.D. Anderson Cancer Center
Berufsverband Niedergelassener Gynäkologischer Onkologen in Deutschland e.V.
Exelixis
The University of Texas Medical Branch, Galveston
New Hope Medical Center
M.D. Anderson Cancer Center